Melatonin and N-acetylcysteine influence on the lipoperoxidation intensity in blood serum and central nervous system of rats with type 1 diabetes mellitus




experimental diabetes mellitus, fatty acids, brain, antioxidants, N-acetylcysteine, melatonin


Topicality. Diabetic encephalopathy has a significant medical and social value, since it is one of the most common complications of diabetes mellitus. Medicines with antioxidative properties play an important role in pathogenetic therapy of diabetic encephalopathy.

Aim. To investigate the effect of melatonin and N-acetylcysteine on the lipoperoxidation intensity in blood serum and central nervous system of rats with streptozotocin – induced diabetes mellitus type 1 (DM1).


Materials and methods. MDA and SOD were studied in homogenate of brain tissues and blood serum of rats (with DM1 received physiological solution; rats with DM1 received per os: N-acetylcysteine at a dose of 1.5 g/kg – (NAC), melatonin – 10 mg/kg (Mel) and combination therapy (NAC + Mel); healthy rats (control group)). Fatty acid composition was determined by gas-liquid chromatography.

Results and discussion. We observed the growth of MDA, reduction of SOD in homogenate of brain tissues and growth of MDA in blood serum of rats with DM comparison groups. Administration of NAC and Mel was contributed to the reduction of MDA concentration and normalization of SOD level in homogenate of brain tissues. Administration of Mel was contributed to the reduction of MDA concentration and growing of SOD in serum blood also. Pharmacotherapy NAC and Mel was caused normalization of the fatty acids in the brain of rats with diabetes type 1: the levels of palmitic and linoleum acids were increased, and the level of arachidonic acid was decreased. Mel increased the level of oleic acid also. NAC in mono- and combination therapy contributed to the improvement of the fatty acid composition in blood serum`s lipids of rats with diabetes mellitus type 1 by reducing the amount of saturated and increasing unsaturated and polyunsaturated fatty acids. Mel also increased the content of unsaturated fatty acids in blood serum.

Conclusions. Therapy of NAC and Mel caused to the decreasing in the intensity of lipoperoxidation in the blood serum and central nervous system of rats with streptozotocin – induced type 1 diabetes mellitus.

Author Biographies

O. A. Fitsner, Bogomolets National Medical University

Postgraduate student, Department of Clinical Pharmacology and Clinical Pharmacy

M. V. Khaitovych, Bogomolets National Medical University

MD, Professor, Head of Department, Department of Clinical Pharmacology and Clinical Pharmacy

T. S. Briuzghina, Bogomolets National Medical University

PhD in Technical Sciences, research associate of Laboratory of Clinical Laboratory Diagnostics in Scientific Research,
Institute of Experimental and Clinical Medicine


Tkachenko, V. I. (2014). Liky Ukrainy, 4, 55–59.

Pankiv V. I. (2012). Pathogenetic treatment of Diabetic Neuropathy: an integrated approach To the practicing endocrinologist. Available


Sözbir, E., & Nazıroğlu, M. (2015). Diabetes enhances oxidative stress-induced TRPM2 channel activity and its control by N-acetylcysteine in rat

dorsal root ganglion and brain. Metabolic Brain Disease, 31 (2), 385–393.

Özcelik, D., Uzun, H., & Nazıroglu, M. (2012). N-Acetylcysteine Attenuates Copper Overload-Induced Oxidative Injury in Brain of Rat. Biological

Trace Element Research, 147 (1-3), 292–298.

Şenol, N., Nazıroğlu, M., & Yürüker, V. (2014). N-Acetylcysteine and Selenium Modulate Oxidative Stress, Antioxidant Vitamin and Cytokine Values

in Traumatic Brain Injury-Induced Rats. Neurochemical Research, 39 (4), 685–692.

Rosa, L. R. de O., Kaga, A. K., Barbanera, P. O., Queiroz, P. M., do Carmo, N. O. L., & Fernandes, A. A. H. (2018). Beneficial effects of N-acetylcysteine

on hepatic oxidative stress in streptozotocin-induced diabetic rats. Canadian Journal of Physiology and Pharmacology, 96 (4), 412–418. https://

Heo, J.-I., Yoon, D. W., Yu, J. H., Kim, N. H., Yoo, H. J., Seo, J. A., … Kim, N. H. (2018). Melatonin improves insulin resistance and hepatic steatosis

through attenuation of alpha-2-HS-glycoprotein. Journal of Pineal Research, e12493.

Konenkov, V. I., Klimontov, V. V., Michurina, S. V. Prudnikova, M. A., Ishchenko, I. Iu. (2013). Saharnyj diabet, 2, 11–16.

Kadry, S. M., El-Dakdoky, M. H., Haggag, N. Z., Rashed, L. A., & Hassen, M. T. (2018). Melatonin improves the therapeutic role of mesenchymal stem

cells in diabetic rats. Toxicology Mechanisms and Methods, 28 (7), 529–538.

Zhou, H., Yue, Y., Wang, J., Ma, Q., & Chen, Y. (2018). Melatonin therapy for diabetic cardiomyopathy: A mechanism involving Syk-mitochondrial

complex I-SERCA pathway. Cellular Signalling, 47, 88–100.

Bicer, M., Baltaci, S. B., Patlar, S., Mogulkoc, R., & Baltaci, A. K. (2018). Melatonin has a protective effect against lipid peroxidation in the bone tissue

of diabetic rats subjected to acute swimming exercise. Hormone Molecular Biology and Clinical Investigation, 0 (0).


Mehrzadi, S., Motevalian, M., Rezaei Kanavi, M., Fatemi, I., Ghaznavi, H., & Shahriari, M. (2018). Protective effect of melatonin in the diabetic rat

retina. Fundamental & Clinical Pharmacology, 32 (4), 414–421.

Seyit, D., Degirmenci, E., & Oguzhanoglu, A. (2016). Evaluation of Electrophysiological Effects of Melatonin and Alpha Lipoic Acid in Rats with Streptozotocine Induced Diabetic Neuropathy. Experimental and Clinical Endocrinology & Diabetes, 124 (05), 300–306.

Rafieian-Kopaei, M., Sharafati-Chaleshtori, R., Shirzad, H., & Soltani, A. (2017). Melatonin and human mitochondrial diseases. Journal of Research

in Medical Sciences, 22 (1), 2.

Council Directive 2010/63/EU of 22 September 2010 on the protection of animals used for scientific purposes. (2010). Official Journal of the

European Communities, 276, 33–79.

Stefanov, O. V. (2001). Doklinichni doslidzhennya likarskih zasobiv. Kyiv: «Avitsena», 528.

Stalnaia, I. D., Havryshvili, T.H. (1977). Metod opredeleniia MDA s pomoshchiu tiobarbiturovoi kisloty. Orekhovycha, V. N. (ed). Sovremennye metody v biokhimii. M.: Meditcina, 66–67.

Sirota, T. V. (1999). Voprosy meditcinskoi khimii, 45 (3), 263–271.

Yaremenko, O. B., Briuzghina, T. S., Kamysh, T. S., Vretyk, H. M. (2005). Medychna khimiia, 7 (2), 86–88.

Lamazian, H. R., Sytnyk, I. M., Natrus, L. V., Bruzgina, T. S., Chernovol, P. A., & Rizhko, I. M. (2016). Investigation of antioxidant defense mechanisms

of Citrullus Colocynthis fruits and N-acetylcysteine in the diabetes mellitus model on rats. Zaporozhye Medical Journal, 0 (5). https://

Nahorna, O. O., Horchakova, N. O., Chekman, I. S., Bielenichev, I., Briuzghina, T. (2014). Farmakolohiia ta likarska toksykolohiia, 1, 73–77.

Katiuzhinskaia, S. G. (2014). Aktualnye problemy transportnoi meditciny, 155–160.





Pharmacology and biochemistry